IDO2 (Human) Cell Binding Assay, HEK293/IDO2-based (CAT#: ITS-1122-LX64)

HEK293/IDO2 (Human)

Human

Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. Recombinant HEK293 cell line expressing tetracycline-inducible human indoleamine 2,3-dioxygenase (IDO2), Genbank accession number NM_194294. Which can be used in binding assays and functional assay.

HEK293

Cancer

Oncology

In Vitro Cell Binding Assay

Useful for validating the binding affinity of IDO2 (Human) binding molecules (such as anti-IDO2 antibody, ADC) in a cellular context.

Cell-based binding assay is one of most commonly used assays for drug discovery and screening. Creative Biolabs provides In Vitro IDO2 (Human) Cell Binding Assay to validate the binding affinity of 4-1BB (Human) binding molecules (such as anti-4-66BB antibody, ADC) by cell-based ELISA or cell-based FACS analysis. The assay will be customized according to the client's specific requirements. Please contact our scientists to discuss more details.

Cell-based Binding Assay; Cell-based ELSA Binding; Cell-based FACS Binding

Cell Binding Assay

Validating the binding affinity of IDO2 (Human) binding molecules (such as anti-IDO2 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.

Creative have developed the stable cell line HEK293/IDO2 (Human), which is designed for validating the binding affinity of IDO2 (Human) binding molecules (such as anti-IDO2 antibody, ADC) by cell-based ELISA or cell-based FACS analysis.